Blar i HV - Institutt for naturvitenskapelige helsefag på tidsskrift "Journal of Nuclear Medicine"
Viser treff 1-2 av 2
-
Biodistribution and dosimetry results from a phase 1 trial of therapy with the antibody-Radionuclide conjugate 177Lu-Lilotomab satetraxetan
(Journal of Nuclear Medicine;April 1, 2018; Vol. 59, no. 4, Journal article; Peer reviewed, 2018-08-28)177Lu-lilotomab satetraxetan is a novel antibody radionuclide conjugate (ARC) currently in a phase 1/2a first-in-human dosage escalation trial for patients with relapsed CD37+ indolent non Hodgkin lymphoma (NHL). The ... -
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
(Peer reviewed; Journal article, 2023)In preparation for an a-particle therapy trial using 1–7 MBq of 224Ra, the feasibility of tomographic SPECT/CT imaging was of interest. The nuclide decays in 6 steps to stable 208Pb, with 212Pb as the principle photon-emitting ...